Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy—Kynurenines Are Important Players
Dániel Sandi(University of Szeged), László Vécsei(University of Szeged)
Cited by 45
Related Papers
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
|Current Medicinal Chemistry|2017|98
Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms
|International Journal of Molecular Sciences|2023|47
The Power Struggle: Kynurenine Pathway Enzyme Knockouts and Brain Mitochondrial Respiration
|Journal of Neurochemistry|2025|12
Kynurenines and Mitochondrial Disturbances in Multiple Sclerosis
|International Journal of Molecular Sciences|2025|10